FamiCord News
-
Autologus cord blood in autism treatment – new clinical trial in Romania Researchers at Bioforum Foundation have been studying whether intravenous infusions of cord blood stem cells can help young children with autism spectrum disorder (ASD). Read more
-
FamiCord and Vita 34 Vice president speaks on cord blood banking at Advanced Therapies conference in London Tomasz Baran, MD, MBA, Vice President of FamiCord Group and Vita 34, shared his expertise on the evolving field of cord blood… Read more
-
FamiCord Group Central Laboratory with prestigous AABB accrediation The Central Laboratory of the FamiCord Group has achieved prestigious AABB accreditation for Cellular Starting Material (CSM), underscoring FamiCord’s commitment to upholding the highest standards of quality and safety, as well as continuous improvement of procedures related to the preparation of co… Read more
-
Smart Cells International [Famicord Group] chooses Dubai as GCC hub for stem cell banking, expanding global presence Dubai, Feb. 8, 2024— Smart Cells International (SCI), aleading member of FamiCord Group, proudly declares Dubai as its GCC hub for stem cell banking, solidifying its commitment to advancing healthcare solutions in the Middle East. SCI’s decision to establish its state-of-the-art laboratory in Dubai… Read more
-
Yesterday, today and tomorrow: Umbilical cord blood can save lives World Cord Blood Day 2023 15th November 2023, Berlin, Germany: As every year in mid-November global science community celebrates World Cord Blood Day. During that day many events, conferences and workshops take place around the world. Read more
-
FamiCordTx launches first in human application of CAR-T drug candidates FamiCord Group, a leading cell bank in Europe and one of the largest globally, has begun enrollment in Phase I of… Read more